Transcatheter heart valves are viewed as the poster children devices representing the latest in cutting-edge cardiac ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
March 13, 2012 — Asahi Kasei Corp. and Zoll Medical Corp. jointly announced that Asahi Kasei will acquire Zoll for ...
March 13, 2012
March 12, 2012 — Philips introduced the tactically enhanced HeartStart MRx monitor-defibrillator for emergency medical ...
March 12, 2012
March 9, 2012 — Researchers say venom from the green mamba snake may aid in the preservation of cardiac and renal ...
March 09, 2012March 8, 2012 — Researchers at Sentara Cardiovascular Research Institute are among the top enrollers out of 69 leading ...
March 08, 2012
March 8, 2012 — Edwards Lifesciences Corp. reported March 3 it filed its official response to the Centers for Medicare ...
March 08, 2012
March 7, 2012 — Critical Diagnostics announced results from a multi-center study in ambulatory heart failure patients ...
March 07, 2012
March 7, 2012 — The U.S. Patent and Trademark Office (USPTO) granted biopharmaceutical development company BioLineRx for ...
March 07, 2012
March 7, 2012 — Four leading heart organizations representing cardiologists and cardiothoracic surgeons released initial ...
March 07, 2012
March 5, 2012 — SynCardia Systems Inc., manufacturer of the world’s first and only U.S. Food and Drug Administration ...
March 05, 2012
March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the ...
March 05, 2012March 1, 2012 — Philips announced the launch of HeartStart XL+, a crash cart defibrillator/monitor for use in hospitals ...
March 01, 2012February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multicenter Reduce ...
February 29, 2012
February 27, 2012 – Jarvik Heart Inc. announced conditional U.S. Food and Drug Administration (FDA) approval of its ...
February 28, 2012February 24, 2012 — Hospital readmissions continue to be a challenge nationwide. It has been estimated that chronic ...
February 24, 2012